Comparative study of acute effects of single doses of fexofenadine, olopatadine,d-chlorpheniramine and placebo on psychomotor function in healthy volunteers
- 15 December 2003
- journal article
- clinical trial
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 18 (8), 611-618
- https://doi.org/10.1002/hup.538
Abstract
Since most classical (first‐generation) antihistamines have undesirable sedative effects on the central nervous system (CNS), newer (second‐generation) antihistamines have been developed to relieve the sedative effects and to improve the patient's quality of life. However, the psychomotor profiles of second‐generation antihistamines are not fully elucidated. In this randomized, double‐blind, crossover study, the acute effects of single doses of second‐generation antihistamines, fexofenadine (120 mg) and olopatadine (10 mg), on cognitive and psychomotor performance were investigated in comparison with those of placebo and d‐chlorpheniramine (4 mg), a first‐generation antihistamine, using objective and subjective assessments, in 11 healthy Japanese volunteers. In a battery of psychomotor tests, d‐chlorpheniramine impaired tracking ability in the compensatory tracking task and caused a reduction in behavioural activity as continuously measured by wrist actigraphy. Olopatadine, like d‐chlorpheniramine, reduced the behavioural activity, while fexofenadine had no effect in any of the tests. No significant changes in the subjects' self‐ratings of drowsiness were found with the three antihistamines. These results suggest that d‐chlorpheniramine and olopatadine, but not fexofenadine, produce sedative effects on psychomotor performance, and that the CNS profile of fexofenadine is different from that of olopatadine. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 28 references indexed in Scilit:
- Neuroimaging of histamine H1‐receptor occupancy in human brain by positron emission tomography (PET): A comparative study of ebastine, a second‐generation antihistamine, and (+)‐chlorpheniramine, a classical antihistamineBritish Journal of Clinical Pharmacology, 2001
- Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 1999
- A double‐blind, placebo‐controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor functionBritish Journal of Clinical Pharmacology, 1999
- Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performanceJournal of Allergy and Clinical Immunology, 1998
- Efficacy and Safety of Fexofenadine Hydrochloride for Treatment of Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1997
- Sedative effects of antihistamines: safety, performance, learning, and quality of lifeClinical Therapeutics, 1997
- The Effects of Practice on Choice Reaction Time and Critical Flicker Fusion ThresholdHuman Psychopharmacology: Clinical and Experimental, 1997
- Comparison of a new antihistaminic and antiallergic compound KW 4679 with terfenadine and placebo on skin and nasal provocation in atopic individualsClinical and Experimental Allergy, 1994
- The therapeutic index of newer H1-receptor antagonistsClinical and Experimental Allergy, 1994
- Effects of Smoking on Rapid Information Processing PerformanceNeuropsychobiology, 1983